LATEST
Silgan / Trivium: minority stakenewBF International Best Fields Best Food / DiagramnewOpenWorld agreed to acquire Blocksight HoldingsnewMerck KGaA agreed to acquire Silence TherapeuticsLarry A. Powalisz / Adia LabsTTM Technologies / Ophir® Optics businessTradeweb Markets agreed to acquire Trumid HoldingsCentrus Energy / Westerman HoldingsTCGX Acquisition / TriGemX BioArlington Capital Partners / Gooch & HousegoJanus Henderson Investors agreed to acquire four mutual funds managed by Nicholas CompanyPlatinum Equity / Trime: majority stake
Open App
Agreement signedPublished 28 May 2024

Royalty Pharma /
Agios Pharmaceuticals, Inc.

Royalty Pharma to purchase Agios royalty rights for $905 million

Buy side: Royalty Pharma
Buy sideRoyalty Pharma
Target: Agios Pharmaceuticals, Inc.
TargetAgios Pharmaceuticals, Inc.
Source · 28 May 2024Source-verified
See the source
Buy side: Royalty Pharma
Buy sideRoyalty Pharma
Target: Agios Pharmaceuticals, Inc.
TargetAgios Pharmaceuticals, Inc.
01 / BuyerRoyalty Pharma
02 / TargetAgios Pharmaceuticals, Inc.
Source-verified
01

What happened

Agios Pharmaceuticals, Inc. agreed to sell Royalty Pharma its rights to a 15% royalty on potential U.S. sales of Servier’s vorasidenib. The $905 million upfront payment is contingent on FDA approval.

Royalty Pharma will receive the full 15% royalty on annual sales up to $1 billion, and 12% on sales above that amount.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Royalty Pharma to purchase Agios royalty rights for $905 million

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.